Allan Jacobson, Ph.D. is a co-founder of PTC and is the Gerald L. and Zelda S. Haidak Distinguished Professor of Cell Biology at the University of Massachusetts Chan Medical School. He has served as a member of the PTC board of directors since the company’s inception in 1998, previously served as Chairman of the board of directors from 1998 to 2004, and, since 2000, has served as Chairman of the scientific advisory board. In 1982, Dr. Jacobson co-founded Applied bioTechnology, Inc., a biotechnology company, and served as its chairman until its sale in 1991. From 1987 to 1990, Dr. Jacobson served as special limited partner at Euclid Partners, a venture capital firm. Dr. Jacobson has been the Chairman of the Department of Microbiology and Physiological Systems at the UMass Chan Medical School since 1994, and in 2014, was awarded the Medical School’s Chancellor’s Medal for Distinguished Scholarship. Dr. Jacobson received a Ph.D. from Brandeis University in 1971 and has authored over 100 publications in the field of post-transcriptional control processes. He is an elected member of the American Academy of Microbiology and the American Academy of Arts and Sciences, and is co-recipient of the 2023 Gruber Prize in Genetics.